Vascular Disease in COPD: Systemic and Pulmonary Expression of PARC (Pulmonary and Activation-Regulated Chemokine)

PLoS ONE - United States
doi 10.1371/journal.pone.0177218
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Systemic and Pulmonary Vascular Remodelling in Chronic Obstructive Pulmonary Disease

PLoS ONE
Multidisciplinary
2016English

Identification of Biologically Active Chemokine Isoforms From Ascitic Fluid and Elevated Levels of CCL18/Pulmonary and Activation-Regulated Chemokine in Ovarian Carcinoma

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2002English

CCR5 Expression and CC Chemokine Levels in Idiopathic Pulmonary Fibrosis

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2005English

Overview: Pulmonary Vascular Function in Health and Disease

Journal of Physiology
PhysiologySports Science
2019English

Pulmonary Vascular K+channel Expression and Vasoreactivity in a Model of Congenital Heart Disease

American Journal of Physiology - Lung Cellular and Molecular Physiology
PulmonaryRespiratory MedicinePhysiologyCell Biology
2002English

Inhaled and Systemic Corticosteroids in Chronic Obstructive Pulmonary Disease

Proceedings of the American Thoracic Society
2008English

Pulmonary Vascular Disease in Secundum Atrial Septal Defect With Pulmonary Hypertension

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
1986English

Influence of Indomethacin on the Systemic and Pulmonary Vascular Resistance in Man

Clinical Science
1978English

Balance Impairment and Systemic Inflammation in Chronic Obstructive Pulmonary Disease

International Journal of COPD
EnvironmentalPublic HealthHealth PolicyMedicinePulmonaryRespiratory MedicineOccupational Health
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy